Výsledky vyhledávání - "M. W. Hofmann"

POS0615 TOCILIZUMAB IS SAFE AND EFFECTIVE IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS

Autor: Frank Moosig, G.-R. Burmester, G. Fliedner, M. A. Peters, Ch. Specker, Martin Aringer, H-P Tony, Herbert Kellner, M. W. Hofmann

Publikováno v: Annals of the Rheumatic Diseases. 80:544.2-545

Background:Average life spans of patients with rheumatoid arthritis (RA) are approaching those of the general population. This results in a large proportion of RA patients being elderly at some point and underlines effective RA treatments needed for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b11a2c9b5274c881676a3d99caa7d850
https://doi.org/10.1136/annrheumdis-2021-eular.1711

Zobrazit plný text záznamu

FRI0054 CHANGES IN DEPRESSIVE SYMPTOMS IN RHEUMATOID ARTHRITIS (RA) PATIENTS DURING TOCILIZUMAB (TCZ) THERAPY: THE GERMAN NONINTERVENTIONAL ARATA STUDY

Autor: G.-R. Burmester, Anke Liebhaber, Frank Behrens, Martin Feuchtenberger, C. Amberger, C. Luig, M. W. Hofmann, M. Sieburg, C. Kühne, Herbert Kellner, Siegfried Wassenberg

Publikováno v: Annals of the Rheumatic Diseases. 79:603.2-603

Background:Depression is a common comorbidity in patients with RA and influences perception of disease activity and quality of life. We have previously reported that mean depression scores improved during TCZ therapy in conjunction with reductions in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffc32f22f3eaabd7d50a70b41ae62623
https://doi.org/10.1136/annrheumdis-2020-eular.4535

Zobrazit plný text záznamu

SAT0182 Tocilizumab s.c. – improvement of the depressiveness, fatigue and pain in ra therapy

Autor: W. A. Biewer, M. W. Hofmann, Martin Feuchtenberger, G.-R. Burmester, Peter Kastner, T. Klopsch, C. Kühne, Herbert Kellner, H-P Tony, J.-P. Flacke, Matthias Englbrecht, C. Amberger, Frank Behrens

Publikováno v: Saturday, 16 JUNE 2018.

Background: The non-interventional ARATA study (NCT02251860) observes the clinical effectiveness and safety of subcutaneous Tocilizumab [TCZ] s.c. treatment under routine conditions over a 2-year period. Objectives: In this interim analysis, the trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00b196ae25acebe632e656964ee24d8a
https://doi.org/10.1136/annrheumdis-2018-eular.2176

Zobrazit plný text záznamu

FRI0117 Tocilizumab use directly after sdmard failure shows higher response rates and a longer treatment duration

Autor: M. W. Hofmann, Herbert Kellner, C. Kühne, H-P Tony, C. Amberger, Peter Kastner, Martin Feuchtenberger, G.-R. Burmester, Frank Behrens, T. Klopsch, W. A. Biewer, J.-P. Flacke

Publikováno v: FRIDAY, 15 JUNE 2018.

Background The non-interventional study (NIS) ARATA (NCT02251860) observes the clinical effectiveness and safety of subcutaneous Tocilizumab (TCZ) s.c. treatment under routine conditions over a 2 year period. Objectives In this interim analysis, the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86d55ec6169ecd8b53794df2b9a11220
https://doi.org/10.1136/annrheumdis-2018-eular.2166

Zobrazit plný text záznamu

AB0396 Tocilizumab i.v. effectiveness in ra patients is independent of smoking status

Autor: Ch. Specker, Martin Aringer, M. W. Hofmann, J.-P. Flacke, I Schwarze, G. Fliedner, C. Volberg, V Braunewell, H-P Tony, Peter Kastner, M. Sieburg, Herbert Kellner

Publikováno v: Abstracts Accepted for Publication.

Background Cigarette smoking is considered an established risk factor for the development of rheumatoid arthritis (RA) and for poor response in RA patients to treatment with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0dcf3de8702f927f12b519a85131cf63
https://doi.org/10.1136/annrheumdis-2017-eular.5923

Zobrazit plný text záznamu

SAT0193 Ra patients with inflammatory anemia benefit from increased hemoglobin and decreased fatigue under tocilizumab therapy

Autor: V Braunewell, H-P Tony, Martin Aringer, J.-P. Flacke, G. Fliedner, I Schwarze, C. Volberg, Ch. Specker, M. Sieburg, Peter Kastner, M. W. Hofmann, Herbert Kellner

Publikováno v: Poster Presentations.

Background According to WHO definition approximately 15% of all patients with rheumatoid arthritis (RA) suffer from anemia (hemoglobin Objectives The 6th interim analysis of the non-interventional ICHIBAN study (NCT01194401) evaluated the occurrence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::025b911b97b43eea8a5616c09eff3b31
https://doi.org/10.1136/annrheumdis-2017-eular.5876

Zobrazit plný text záznamu

SAT0060 Achievement of Individual Important Response Measured by Das28dcrit in Active Rheumatoid Arthritis When Treated with Tocilizumab: Data from A Large Prospective Observational Study

Autor: Harald Burkhardt, Ch. Specker, G. Fliedner, M. Köhm, M. W. Hofmann, Frank Behrens

Publikováno v: Annals of the Rheumatic Diseases. 75:686.1-686

Background Normal fluctuations in results of disease activity measurements due to short-term situational effects and measurement errors are issues for evaluation of individual clinically meaningful therapeutic response in daily practice in patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e8311842508feddadda494f0bdc1c1e
https://doi.org/10.1136/annrheumdis-2016-eular.5739

Zobrazit plný text záznamu

FRI0142 High Prevalence of Depression in Patients with Rheumatoid Arthritis - Data from The Large Cross-Sectional Vadera II Study

Publikováno v: Annals of the Rheumatic Diseases. 75:479.2-480

Background Depression is a frequent if not the most frequent comorbidity in patients with rheumatoid arthritis (RA) [1]. Objectives To investigate the prevalence of depressive symptoms in RA patients in a standardized manner in the clinical setting u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c8239469748d5b3f547c37b4c8112b8
https://doi.org/10.1136/annrheumdis-2016-eular.3236

Zobrazit plný text záznamu

FRI0202 Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis

Autor: Ch. Specker, V Braunewell, H-P Tony, Peter Kastner, J. Kaufmann, J.-P. Flacke, G. Fliedner, L. Meier, A. Aringer, M. Sieburg, C. Volberg, M. W. Hofmann, Herbert Kellner

Publikováno v: Annals of the Rheumatic Diseases. 75:504.1-504

Background The single-arm non-interventional study ICHIBAN was set up to evaluate the effectiveness and safety of intravenously administered Tocilizumab (TCZ IV) in patients (pts) with moderate to severe rheumatoid arthritis (RA) in Germany. Clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dab7e307854421284b340938f0c58785
https://doi.org/10.1136/annrheumdis-2016-eular.3424

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání